2results about How to "Suppressed expression level" patented technology

This invention discloses a cyclic nonapeptide with both anti-photoaging and antioxidant effects. The amino acid sequence of the cyclic nonapeptide is: cyclic (arginine-glycine-aspartic acid-serine-asparagine-lysine-valine-lysine-phenylalanine). The cyclic nonapeptide of this invention can effectively reduce deep photoaging caused by UVA and surface oxidative damage induced by UVB, thereby achieving comprehensive skin protection.

The present application relates to the technical field of medicine, and provides application of Ben Dung decoction in preparation of medicine for treating ovarian cancer, wherein the Ben Dung decoction is prepared from licorice, Szechuan lovage rhizome, Chinese angelica, pinellia, radix scrophulariae, radix puerariae, radix paeoniae, ginger and root white bark of prunus mira koehne with a mass ratio of (1.5-2.5):(1.5-2.5):(1.5-2.5):(3-5):(1-3):(6-10):(1.5-2.5):(3-5):(4-7). The Ben Dung decoction can significantly affect the morphology and cycle of ovarian cancer ES-2 and OV-1063 cells, effectively inhibit the malignant phenotypes such as proliferation, migration, infiltration and cloning of the ovarian cancer ES-2 and OV-1063 cells, and inhibit the expression level of CA125 and CEA proteins in the ovarian cancer OV-1063 cells.